Aprameya Engineering Ltd vs Galaxy Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aprameya Engineering Ltd is ₹ 89.9 as of 23 Oct 15:30 . The P/E Ratio of Aprameya Engineering Ltd is 12.1 as of March 2025 .The P/E Ratio of Galaxy Medicare Ltd is 0 as of March 2025 . The Market Cap of Aprameya Engineering Ltd is ₹ 194.97 crore as of March 2025 .The Market Cap of Galaxy Medicare Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Aprameya Engineering Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Galaxy Medicare Ltd changed from 9.72 % on March 2021 to 31.05 % on March 2026 . This represents a CAGR of 21.36% over 6 years .

About Aprameya Engineering Ltd

Aprameya Engineering Limited was originally formed as a partnership firm in the name and style of 'M/s.
Aprameya Engineering' pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad.
Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm 'M/s.
Aprameya Engineering' to a Private Limited Company.
Further, Company converted into a Public Limited Company and its name was changed from 'Aprameya Engineering Private Limited' to 'Aprameya Engineering Limited' vide a fresh Certificate of Incorporation upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad. Company is a trusted partner in India's healthcare infrastructure space, with over two decades of experience in delivering turnkey hospital projects and integrated medical technology solutions across public and private sectors.

About Galaxy Medicare Ltd

Galaxy Medicare Limited was originally established on July 23, 1992 as a Limited Company in the Mancheshwar Industrial area of Bhubaneswar, Orissa.
The Company commenced its operations in 1992 when the founder, Mr. Dillip Kumar Das, acquired a closed business unit, M/s Cure Aids Private Limited from Odisha Industrial Infrastructure Development Corporation (IDCO) and Odisha State Financial Corporation under the investment promotion, facilitation and aftercare strategy of Industrial Promotion and Investment Corporation of Odisha (IPICOL) and revived the business unit to start manufacturing of Medical Devices such as Plaster of Paris Bandage (POP Bandage), Medical Tapes and Bandages, Other surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, etc.

FAQs for the comparison of Aprameya Engineering Ltd and Galaxy Medicare Ltd

Which company has a larger market capitalization, Aprameya Engineering Ltd or Galaxy Medicare Ltd?

Market cap of Aprameya Engineering Ltd is 171 Cr while Market cap of Galaxy Medicare Ltd is 27 Cr

What are the key factors driving the stock performance of Aprameya Engineering Ltd and Galaxy Medicare Ltd?

The stock performance of Aprameya Engineering Ltd and Galaxy Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aprameya Engineering Ltd and Galaxy Medicare Ltd?

As of October 24, 2026, the Aprameya Engineering Ltd stock price is INR ₹89.9. On the other hand, Galaxy Medicare Ltd stock price is INR ₹18.05.

How do dividend payouts of Aprameya Engineering Ltd and Galaxy Medicare Ltd compare?

To compare the dividend payouts of Aprameya Engineering Ltd and Galaxy Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.